Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  HIV Infection

  Free Subscription


2 AIDS Res Hum Retroviruses
1 Int J Cancer
3 J Infect Dis
1 J Med Virol
1 Nat Med
2 Nature
1 Pediatr Infect Dis J
9 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. CHEN RQ, Zino L, Geerlings S, Colbers A, et al
    Exposure to doravirine, lamivudine, tenofovir, and raltegravir in a patient with HIV after a Roux-en-Y gastric bypass.
    AIDS. 2023;37:1769-1771.

  2. HOVE-SKOVSGAARD M, Hogh J, Pham MHC, Knudsen AD, et al
    Peripheral T-cell activation, Th17 cells, regulatory T-cells, and aortic aneurysm in people with HIV.
    AIDS. 2023;37:1765-1767.
    PubMed         Abstract available

  3. WATERS L, Woolley I
    More evidence for inequitable COVID-19 outcomes in people with HIV.
    AIDS. 2023;37:1763-1764.

    Is there a link between antiretroviral therapy and hypertensive disorders of pregnancy?
    AIDS. 2023;37:1759-1761.

    A new look at human leukocyte antigen variation in HIV; functional clustering to enhance power for discovery of host genetic associations.
    AIDS. 2023;37:1757-1758.

  6. ZUCCO AG, Bennedbaek M, Ekenberg C, Gabrielaite M, et al
    Associations of functional human leucocyte antigen class I groups with HIV viral load in a heterogeneous cohort.
    AIDS. 2023;37:1643-1650.
    PubMed         Abstract available

  7. FILIP I
    Cerebrospinal fluid viral escape can provide clues for the management of HIV-associated neurologic complications: Highlights from the 2023 American Academy of Neurology Annual Meeting, Boston.
    AIDS. 2023;37:N9-N10.

  8. BENGTSON AM, Madlala H, Matjila MJ, Levitt N, et al
    Associations of HIV and antiretroviral therapy with gestational diabetes: findings from a prospective cohort in South Africa.
    AIDS. 2023 Aug 3. doi: 10.1097/QAD.0000000000003678.
    PubMed         Abstract available

  9. COSTINIUK CT, Singer J, Lee T, Galipeau Y, et al
    Antibody neutralization capacity after COVID-19 vaccination in people with HIV (CIHR Canadian HIV trials network 328).
    AIDS. 2023 Aug 3. doi: 10.1097/QAD.0000000000003680.
    PubMed         Abstract available

  10. MAKINSON A, Allavena C, Abulizi X, Slama L, et al
    Frailty and pre-frailty phenotypes increase the odds of abnormal cognitive impairment screens in people living with HIV.
    AIDS. 2023 Aug 3. doi: 10.1097/QAD.0000000000003681.
    PubMed         Abstract available

  11. MATOGA M, Chen JS, Massa C, Thengolose I, et al
    HIV and urethritis: Time required for antiretroviral therapy to suppress HIV in semen.
    AIDS. 2023 Aug 3. doi: 10.1097/QAD.0000000000003679.
    PubMed         Abstract available

    AIDS Res Hum Retroviruses

  12. MALLIPEDDI VP, Levy M, Byrne M, Monroe A, et al
    Evaluation of New Hypertension Guidelines on the Prevalence and Control of Hypertension in a Clinical HIV Cohort: A Community-Based Study.
    AIDS Res Hum Retroviruses. 2023 Aug 1. doi: 10.1089/AID.2022.0063.
    PubMed         Abstract available

  13. DI CARLO D, Falasca F, Mazzuti L, Guerrizio G, et al
    MicroRNA Expression Levels in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus Type 1 Positive Individuals and Relationship with Different Levels of Viral Suppression.
    AIDS Res Hum Retroviruses. 2023 Jul 31. doi: 10.1089/aid.2022.0165.
    PubMed         Abstract available


  14. BILLICK MJ, Sheps J, Bogoch II
    HIV prevention with postexposure prophylaxis-in-pocket (PIP).
    BMJ. 2023;382:e076016.

    Int J Cancer

  15. HUANG J, Chan SC, Fung YC, Pang WS, et al
    Global incidence, risk factors and trends of vulvar cancer: A country-based analysis of cancer registries.
    Int J Cancer. 2023 Aug 2. doi: 10.1002/ijc.34655.
    PubMed         Abstract available

    J Infect Dis

  16. SCEVOLA S, Niubo J, Domingo P, Verdejo G, et al
    Decay of human immunodeficiency virus (HIV) RNA in seminal plasma and rectal fluid in treatment-naive adults starting antiretroviral therapy with dolutegravir plus lamivudine or bictegravir/emtricitabine/tenofovir alafenamide.
    J Infect Dis. 2023 Aug 1:jiad304. doi: 10.1093.
    PubMed         Abstract available

  17. BRAUNSTEIN SL, Wahnich A, Lazar R
    COVID-19 outcomes among people with HIV and COVID-19 in New York City.
    J Infect Dis. 2023 Aug 3:jiad311. doi: 10.1093.
    PubMed         Abstract available

  18. SABOURIN KR, Ogolla S, Samayoa Reyes G, Daud I, et al
    Effects of maternal HIV infection on early Kaposi's sarcoma-associated herpesvirus (KSHV) seroconversion in a Kenyan mother-infant cohort.
    J Infect Dis. 2023 Aug 4:jiad310. doi: 10.1093.
    PubMed         Abstract available

    J Med Virol

  19. LI R, Lin C, Dong S, Li J, et al
    Phylogenetics and phylogeographic characteristics of coxsackievirus A16 in hand foot and mouth disease and herpangina cases collected in Beijing, China from 2019 to 2021.
    J Med Virol. 2023;95:e28991.
    PubMed         Abstract available

    Nat Med

    Balancing the risks of HIV transmission at low viral load.
    Nat Med. 2023 Aug 3. doi: 10.1038/d41591-023-00068.


  21. MCLAREN PJ, Porreca I, Iaconis G, Mok HP, et al
    Africa-specific human genetic variation near CHD1L associates with HIV-1 load.
    Nature. 2023 Aug 2. doi: 10.1038/s41586-023-06370.
    PubMed         Abstract available

  22. Variation in African genomes linked to control of HIV.
    Nature. 2023 Aug 2. doi: 10.1038/d41586-023-02277.

    Pediatr Infect Dis J

  23. CHABALA C, Turkova A, Kapasa M, LeBeau K, et al
    Inadequate Lopinavir Concentrations With Modified 8-hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIV.
    Pediatr Infect Dis J. 2023 Jul 20. doi: 10.1097/INF.0000000000004047.
    PubMed         Abstract available

    PLoS One

  24. KAO SZ, Tutwiler MS, Ekwueme DU, Truman BI, et al
    Better data for decision-making through Bayesian imputation of suppressed provisional COVID-19 death counts.
    PLoS One. 2023;18:e0288961.
    PubMed         Abstract available

  25. ENDRIYAS M, Shibru E, Hussen M, Melka M, et al
    Knowledge, attitudes and practices towards COVID-19: Community survey in southern Ethiopia.
    PLoS One. 2023;18:e0288430.
    PubMed         Abstract available

  26. LARCOMBE L, Ringaert L, Restall G, McLeod A, et al
    "Because of COVID...": The impacts of COVID-19 on First Nation people accessing the HIV cascade of care in Manitoba, Canada.
    PLoS One. 2023;18:e0288984.
    PubMed         Abstract available

  27. PARMLEY LE, Nkumbula T, Chilukutu L, Chelu L, et al
    Impacts of COVID-19 on sexual risk behaviors, safe injection practices, and access to HIV services among key populations in Zambia: Findings from a rapid qualitative formative assessment.
    PLoS One. 2023;18:e0289007.
    PubMed         Abstract available

  28. TAVAKOLI F, Moradi G, Mirzazadeh A, Zarei B, et al
    HIV testing and its associated factors among female sex workers in Iran in 2020: Finding from a respondent-driven sampling survey.
    PLoS One. 2023;18:e0289307.
    PubMed         Abstract available

  29. KABORE OD, Millogo A, Sanogo B, Birba E, et al
    Analytical performances of the Xpert MTB/RIF assay using stool specimens to improve the diagnosis of pulmonary tuberculosis in Burkina Faso, a tuberculosis endemic country.
    PLoS One. 2023;18:e0288671.
    PubMed         Abstract available

  30. DALY FP, O'Donnell K, Davoren MP, Noone C, et al
    Recreational and sexualised drug use among gay, bisexual, and other men who have sex with men (gbMSM) in Ireland-Findings from the European MSM internet survey (EMIS) 2017.
    PLoS One. 2023;18:e0288171.
    PubMed         Abstract available

  31. MOLLALIGN H, Getahun M, Diriba G, Alemu A, et al
    Genetic diversity and drug sensitivity profile of Mycobacterium tuberculosis among children in Ethiopia.
    PLoS One. 2023;18:e0284363.
    PubMed         Abstract available

  32. MUKOKA M, Sibanda E, Watadzaushe C, Kumwenda M, et al
    COVID-19 self-testing using antigen rapid diagnostic tests: Feasibility evaluation among health-care workers and general population in Malawi.
    PLoS One. 2023;18:e0289291.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.